首页> 美国卫生研究院文献>Viruses >Effect of Bacteriophage Infection in Combination with Tobramycin on the Emergence of Resistance in Escherichia coli and Pseudomonas aeruginosa Biofilms
【2h】

Effect of Bacteriophage Infection in Combination with Tobramycin on the Emergence of Resistance in Escherichia coli and Pseudomonas aeruginosa Biofilms

机译:噬菌体感染与妥布霉素联合使用对大肠杆菌和铜绿假单胞菌生物膜耐药性产生的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bacteriophage infection and antibiotics used individually to reduce biofilm mass often result in the emergence of significant levels of phage and antibiotic resistant cells. In contrast, combination therapy in Escherichia coli biofilms employing T4 phage and tobramycin resulted in greater than 99% and 39% reduction in antibiotic and phage resistant cells, respectively. In P. aeruginosa biofilms, combination therapy resulted in a 60% and 99% reduction in antibiotic and PB-1 phage resistant cells, respectively. Although the combined treatment resulted in greater reduction of E. coli CFUs compared to the use of antibiotic alone, infection of P. aeruginosa biofilms with PB-1 in the presence of tobramycin was only as effective in the reduction of CFUs as the use of antibiotic alone. The study demonstrated phage infection in combination with tobramycin can significantly reduce the emergence of antibiotic and phage resistant cells in both E. coli and P. aeruginosa biofilms, however, a reduction in biomass was dependent on the phage-host system.
机译:噬菌体感染和单独用于减少生物膜质量的抗生素通常会导致大量噬菌体和抗生素抗性细胞的出现。相比之下,在采用T4噬菌体和妥布霉素的大肠杆菌生物膜中进行联合治疗可分别使抗生素和噬菌体抗性细胞减少超过99%和39%。在铜绿假单胞菌生物膜中,联合治疗分别使抗生素和PB-1噬菌体抗性细胞减少60%和99%。尽管与单独使用抗生素相比,联合治疗导致大肠杆菌CFU的减少更大,但是在妥布霉素存在下用PB-1感染铜绿假单胞菌生物膜与减少抗生素的效果一样。单独。该研究表明,噬菌体感染与妥布霉素联合使用可显着减少大肠杆菌和铜绿假单胞菌生物膜中抗生素和噬菌体抗性细胞的出现,但是生物量的减少取决于噬菌体-宿主系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号